🔗 Share this article

Grammy-winning soul vocalist D’Angelo died on October 14 at age 51 after a personal fight with pancreatic cancer.

“The brilliant light of our household has faded away for us in the present world,” his relatives confirmed. “After a lengthy and brave struggle with the disease, we are heartbroken to declare that D’Angelo, known to his followers around the globe as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on music with his innovative neo-soul sound and partnerships with renowned musicians.

He launched his first record, “Brown Sugar,” in 1995 to immediate acclaim. The album achieved the fourth spot on the R&B charts, earned platinum status later that year, and earned multiple award nominations.

However, it was his second album, “Voodoo,” in 2000 that propelled his artistic journey into the limelight. The album debuted at No. 1 on both Billboard’s Top R&B Albums chart and the main album chart. He received two Grammys: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a hesitant one, in the public consciousness. The personal depiction featured the singer, notably stripped down to his waist, singing straight into the lens.

D’Angelo retreated from the spotlight after releasing Voodoo and publicly struggled with substance abuse. In 2005, he was part of a serious car crash that left him in critical condition.

More than a decade later, his third and final album, “Black Messiah” (2014), reaffirmed his enduring appeal with another top chart entry on the soul music rankings and a award for Top R&B Record.

Again, in his own mysterious way, D’Angelo made only a few public appearances in the following years.

The singer was announced as a top act for the 2025 music event, but his appearance was called off, due to an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s well-being in the months before his death, he had reportedly been in the hospital for an extended period and in palliative care for two weeks.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic malignancy, one of the most deadly and least preventable forms of the disease, on a brilliant talent whose life was ended too soon.

“We are grieved that he can only leave cherished moments with his loved ones, but we are forever thankful for the heritage of deeply emotional music he has left us,” his kin said.

Pancreatic Malignancy: Lethal and Difficult to Avoid

Pancreatic malignancy affects the pancreas, a small organ that produces the hormone insulin and is vital in breaking down food, among other functions. The size and location of the organ in the body make it more difficult to identify cancer.

Although pancreatic cancer makes up only about 3% of cancer diagnoses annually in the U.S., it is causes seven percent of malignancy fatalities.

Almost 70,000 individuals will be found to have pancreatic cancer and roughly 52,000 will die of the illness in 2025.

“Pancreatic cancer is one of the deadliest cancers, with an fast-growing mass and dismal outcomes. We have few and ineffective therapies, and a narrow opportunity to make a meaningful impact on the well-being of patients,” said a cancer specialist.

Since this disease seldom produces initial signs, it’s frequently identified only once the disease is advanced. Although a patient has symptoms they are often vague and may be mistaken for a several everyday ailments.

“As of yet, there is no effective method to detect this malignancy in the initial phases, apart from listening to your body and speaking with your physician if there are new or unusual signs,” explained a medical director.

Frequent indicators of this disease encompass:

• abdominal or lower back pain
• weight loss
• jaundice
• loss of appetite
• dark urine
• light-colored or greasy stools
• loose stools
• excessive hunger or thirst
• feeling sick

At age 51, D’Angelo’s demise is an outlier, as this malignancy is typically found in individuals in the sixty-five to seventy-five range. However, numerous malignancies, such as this type, have become more common in younger people.

“This disease identified prior to fifty is deemed rare, yet alarmingly, doctors are noticing a rising count of younger patients suffering from this condition,” said a expert.

Genetic Background Affects Disease Probability

In the absence of reliable screening tools for pancreatic cancer, experts stressed the importance of knowing your family’s health background. Certain contributing elements, such as smoking and obesity also have an influence in the onset of this disease.

African Americans have the greatest occurrence of this malignancy in the U.S. and are more prone to be diagnosed with inoperable cancer.

“The initial action toward lowering one’s risk of this condition is assessing personal risk factors. People should review their genetic background, genetic background, and medical conditions, such as blood sugar disease, chronic pancreatitis, or overweight that may raise their vulnerability,” advised a medical professional.

Inherited genetic risk factors are linked to as much as 10% of all this malignancy instances. If a relative in your household has had this disease, you may want to consider genetic testing.

“For individuals with a relative’s background of pancreatic cancer or those having high risk DNA changes, screening may involve advanced imaging such as magnetic resonance imaging (MRI) or internal ultrasound to find early changes in the pancreas,” he clarified.

For those wishing to reduce their risk, lifestyle changes may make a difference. The best step you can take to reduce your susceptibility of pancreatic cancer is to quit smoking, and if you are a non-smoker, stay away altogether.

Excessive alcohol consumption is associated with pancreas inflammation, a risk factor for this malignancy, so limiting or abstaining from drinks may assist reduce your risk.

Controlling your body mass or losing weight may also help decrease your susceptibility. Individuals with excess weight are 20% more likely to develop pancreatic cancer. This malignancy also occurs more often in people with blood sugar issues, and reducing weight can also lower the chance of type 2 diabetes.

Despite this disease’s poor prognosis, there is still hope.

“We are doing better with treatments and more recent mixed drug treatments. There are emerging targeted therapies that are already showing results,” remarked a expert.

For many individuals, however, education about this rare but {dev